News Corteva, Inc.

Equities

CTVA

US22052L1044

Real-time Estimate Cboe BZX Other stock markets 12:35:35 2024-04-25 pm EDT			5-day change	1st Jan Change
54.33 ^USD	-0.80%		+0.56%	+13.23%

Apr. 23	UPL Limited completed the acquisition of Cortevas Mancozeb Business from Corteva, Inc..	CI
Apr. 17	Goldman Sachs Adjusts Corteva Price Target to $59 From $56	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UPL Limited completed the acquisition of Cortevas Mancozeb Business from Corteva, Inc..	Apr. 22	CI
Goldman Sachs Adjusts Corteva Price Target to $59 From $56	Apr. 17	MT
Oppenheimer Raises Price Target on Corteva to $67 From $62, Outperform Rating Kept	Apr. 16	MT
North American Morning Briefing : Stock Futures -2-	Apr. 15	DJ
Overreacting much?	Apr. 12
JPMorgan Downgrades Corteva to Neutral From Overweight, Trims Price Target to $57 From $58	Apr. 12	MT
ANALYST RECOMMENDATIONS : Coinbase, Uber, Coca-Cola, Glencore, Shell...	Apr. 12
BofA Securities Raises Price Target on Corteva to $59 From $57, Maintains Neutral Rating	Apr. 10	MT
KeyBanc Raises Price Target on Corteva to $66 From $63, Keeps Overweight Rating	Apr. 09	MT
Jefferies Raises Corteva Price Target to $67 From $64, Maintains Buy Rating	Mar. 28	MT
Corteva Launches Corteva Catalyst	Mar. 19	PR
Corteva, Inc. Launches Corteva Catalyst	Mar. 19	CI
Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast	Mar. 13	PR
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results - Evogene	Mar. 08	AQ
Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules	Mar. 06	MT
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides - Evogene	Mar. 06	AQ
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides	Mar. 06	CI
Wolfe Research Starts Corteva With Outperform Rating	Mar. 01	MT
Transcript : Corteva, Inc. Presents at Bank of America Securities 2024 Global Agriculture and Materials Conference, Feb-28-2024 09:10 AM	Feb. 28
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements - Evogene	Feb. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Corteva, Inc.

Equities

CTVA

US22052L1044

Summary

Filters